These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4835127)

  • 1. Quantitative histological studies on the pathogenesis of uremic bone disease.
    Sherrard DJ; Baylink DJ; Wergedal JE; Maloney NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):119-35. PubMed ID: 4835127
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone histology in metabolic bone disease: the diagnostic value of bone biopsy.
    Parfitt AM; Oliver I; Villanueva AR
    Orthop Clin North Am; 1979 Apr; 10(2):329-45. PubMed ID: 450410
    [No Abstract]   [Full Text] [Related]  

  • 3. A microradiographic study of bone disease in uremia.
    Pellegrino ED; Biltz RM; Pellegrino MJ
    Trans Am Clin Climatol Assoc; 1971; 82():177-87. PubMed ID: 5512224
    [No Abstract]   [Full Text] [Related]  

  • 4. Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient.
    Felsenfeld AJ; Gutman RA; Llach F; Harrelson JM; Wells SA
    Miner Electrolyte Metab; 1984; 10(3):166-72. PubMed ID: 6727802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteopathy in chronic kidney failure].
    Binswanger U; Fischer J; Schenk R; Merz W
    Dtsch Med Wochenschr; 1971 Dec; 96(49):1914-5 passim. PubMed ID: 5127025
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal bone disease.
    Llach F
    Transplant Proc; 1991 Apr; 23(2):1818-22. PubMed ID: 2053165
    [No Abstract]   [Full Text] [Related]  

  • 7. Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
    Teitelbaum SL; Bergfeld MA; Freitag J; Hruska KA; Slatopolsky E
    J Clin Endocrinol Metab; 1980 Aug; 51(2):247-51. PubMed ID: 6893204
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uremic osteodystrophy. Critical evaluation of the radiologic and humoral indices of bone resorption].
    Galmozzi C; Casati S; Rivolta E; De Vecchi A; Imbasciati E; Cecchettin M; Brancaccio D; Ponticelli C
    Minerva Nefrol; 1979; 26(3):405-8. PubMed ID: 262283
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteomalacia after parathyroidectomy in patients with uremia.
    Felsenfeld AJ; Harrelson JM; Gutman RA; Wells SA; Drezner MK
    Ann Intern Med; 1982 Jan; 96(1):34-9. PubMed ID: 7053699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D; Felsenfeld AJ; Voigts A; Llach F
    Kidney Int; 1983 Sep; 24(3):364-70. PubMed ID: 6645210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction.
    Lafage-Proust MH; Combe C; Barthe N; Aparicio M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):512-9. PubMed ID: 10022409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic toxin and bone metabolism.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    J Bone Miner Metab; 2006; 24(2):172-5. PubMed ID: 16502128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic osteodystrophy.
    Prat J; Osborne RL
    Clin Bull; 1976; 6(3):121-4. PubMed ID: 1000788
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
    Brickman AS; Coburn JW; Sherrard DJ; Wong EG; Norman AW; Singer FR
    Contrib Nephrol; 1980; 18():29-41. PubMed ID: 7353378
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential diagnosis of osteopenia.
    Mundy GR
    Hosp Pract; 1978 Nov; 13(11):65-72. PubMed ID: 738713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ultrastructural appearance of bone cells and bone matrix in renal osteodystrophy.
    Robinson RA
    Arch Intern Med; 1969 Nov; 124(5):519-29. PubMed ID: 5345858
    [No Abstract]   [Full Text] [Related]  

  • 20. Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Relationship to osteosclerosis, osteitis fibrosa, and osteoid excess.
    Meema HE; Oreopoulos DG; Rabinovich S; Husdan H; Rapoport A
    Radiology; 1974 Mar; 110(3):513-22. PubMed ID: 4204516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.